The Alfacell Corporation is working on a promising new drug said to kill Mesothelioma cancer cells while sparing other cells in the body. Onconase passed the first test, and Alfacell will reduce expenses in other areas of their business to fund further clinical trials. This is a big gamble, putting their eggs in one basket. We hope the drug is a success and can help Mesothelioma victims.
Richard J. Arsenault, 2011
